Displaying 32 (all) recruiting clinical trials.
-
A Phase 1/2 Multi-Center Open-Label Study to Evaluate the Safety Tolerability and Preliminary Antitumor Activity of TNG348 Single Agent and in Combination with a PARP Inhibitor in Patients with BRCA 1/2 Mutant or Other HRD+ Advanced or Metastatic S
This study is split into two parts: Phase 1 and Phase 2. The study team is testing a new medicine, TNG348, for patients with tumors ...
-
A Phase 1/2 Randomized Study to Evaluate the Safety Tolerability Immunogenicity And Immunopersistence of a Clostridioides Difficile Vaccine Administered in a 2-Dose Regimen with Novel Adjuvants in Healthy Adults
The purpose of this trial is to evaluate the safety and immune effects of an investigational vaccine in healthy volunteers ages 65 and older. This ...